Sign In
Buy PPH
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
01:01pm, Sunday, 26'th Jul 2026
The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and higher assets under management than the VanEck Pharmaceutical ETF VanEck Pharmaceutical ETF focuses e
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
11:53pm, Wednesday, 22'nd Jul 2026
The iShares Global Healthcare ETF provides broader exposure with 110 holdings across various sub-sectors compared to the 26 positions in the VanEck Pharmaceutical ETF The VanEck Pharmaceutical ETF fea
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
10:44am, Monday, 20'th Jul 2026
PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yield beats IXJ by 50 basis points.
AI Bubble Risks Make Dividend Stocks Attractive Again
01:03pm, Saturday, 18'th Jul 2026
I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates qualit
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
08:15am, Thursday, 09'th Jul 2026
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.
4 ETF Winners of June Likely to Gain in July
11:01am, Wednesday, 08'th Jul 2026
These ETF gainers of June may keep climbing in July as dovish Fed hopes, strong earnings and easing geopolitical risks support markets.
Namib Minerals Announces Board and Executive Leadership Appointments to Support Next Phase of Growth
05:25pm, Tuesday, 07'th Jul 2026
New York, July 07, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (Nasdaq: NAMM) ("Namib Minerals" or the "Company") today announced a series of Board and executive leadership appointments to strengthen Boar
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
04:11pm, Saturday, 04'th Jul 2026
The VanEck Pharmaceutical ETF provides a lower expense ratio and a more substantial dividend yield than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF delivered higher 1-year total r
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
05:00pm, Monday, 29'th Jun 2026
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and
Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?
06:21am, Thursday, 18'th Jun 2026
The Vanguard Health Care ETF offers a significantly lower expense ratio than the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF has a higher concentration and higher trailing returns, while
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
01:01pm, Wednesday, 10'th Jun 2026
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:20am, Friday, 05'th Jun 2026
Launched on December 20, 2011, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.
07:51am, Tuesday, 02'nd Jun 2026
Expense ratios, asset size, and portfolio strategy set these two healthcare ETFs apart, yet their risk and dividend profiles tell a different story.
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
09:12am, Wednesday, 27'th May 2026
VanEck Pharmaceutical ETF offers a concentrated portfolio focused exclusively on drug manufacturers. iShares Global Healthcare ETF provides broader diversification across more than 100 companies in th
